What does UNIVERCELLS do?

UNIVERCELLS is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Public Limited, started on 24 January 2013, 4 establishments.

What is the address of UNIVERCELLS?

The registered office of UNIVERCELLS is located at Zoning de Jumet,avenue Centrale 52, 6040 Charleroi.

Is UNIVERCELLS still active?

No. The CBE lists UNIVERCELLS with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is UNIVERCELLS registered on Peppol?

No, UNIVERCELLS is currently not registered on the Peppol network.

What is the enterprise number of UNIVERCELLS?

The enterprise number of UNIVERCELLS is BE0502742288.

When was UNIVERCELLS founded?

UNIVERCELLS was founded on 24 January 2013.

Who are the directors of UNIVERCELLS?

According to the 2023 annual accounts, the directors of UNIVERCELLS are: HUGUES BULTOT, TIMOTHY E. MORRIS, ANDRIN OSWALD, CELINE VAESSEN, JOSE ANTONIO CASTILLO, PIERRE-ARMAND MORGON, DOUGLAS NEUGOLD, GLENN ROCKMAN.

Is UNIVERCELLS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 24 January 2013; 3 annual accounts filed, latest fiscal year 2023; 8 directors known from the annual account; 4 establishments in the CBE.

How much profit did UNIVERCELLS make in 2023?

UNIVERCELLS posted a profit after taxes of € 20,442,747 in financial year 2023.

How much does an employee at UNIVERCELLS earn?

The average wage cost per full-time employee at UNIVERCELLS was € 114,900 in 2023: staff costs of € 9.6 million for 83.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does UNIVERCELLS have?

According to the 2023 annual accounts, UNIVERCELLS has 83.6 full-time equivalents (FTE).

UNIVERCELLS (Public Limited) - Charleroi - BE0502742288

Dossier UNIVERCELLS, printed on 29 October 2026 from databakkes.be/en/0502742288/univercells. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2023

UNIVERCELLS from Charleroi, company number BE0502742288, closed financial year 2023 with a result of € 20.4 million after tax. Compared with financial year 2022, the result moved from € -6.8 million to € 20.4 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 11, 2024.

What it is worth Growing

€ 142.8 million

▲ 31% vs 2022

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 20.4 million

▲ still € 6.8 million loss in 2022

Profit after tax over the fiscal year.

Cash in the bank

€ 3.3 million

▼ 51% vs 2022

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2023. Retained profit grew to € 27.6 million.

People and assets in 2023

Full-time equivalents

83.6

▼ 3.8 vs 2022

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 12.3 million in 2023, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 9.6 million

▼ 1% vs 2022

€ 114,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1.9 million

▲ 2% vs 2022

Of which on lease € 1.7 million.

Debts at end 2023

Bank debt ≈ 92 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 79 million

▲ 5% vs 2022

€ 840,348 is repaid this year. At this pace the long-term loan is gone in ≈ 92 years.

Owed to suppliers

€ 2.1 million

▼ 19% vs 2022

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 58 days on average.

Taxes and wages

€ 2.1 million

▼ 12% vs 2022

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	Change 2022 → 2023
Profit after taxes	€ -8,302,299 Profit after taxes 2021: € -8,302,299 First fiscal year in the series	€ -6,751,720 Profit after taxes 2022: € -6,751,720 ▲ € 1.6 million vs 2021 (€ -8,302,299) Favourable step	€ 20,442,747 Profit after taxes 2023: € 20,442,747 ▲ € 27.2 million vs 2022 (€ -6,751,720) Favourable step	▲ € 27.2 million
Equity	€ 71,569,761 Equity 2021: € 71,569,761 First fiscal year in the series	€ 109,168,897 Equity 2022: € 109,168,897 ▲ 53% vs 2021 (€ 71,569,761) Favourable step	€ 142,840,848 Equity 2023: € 142,840,848 ▲ 31% vs 2022 (€ 109,168,897) Favourable step	▲ 31%
Total debts	€ 69,106,988 Total debts 2021: € 69,106,988 First fiscal year in the series	€ 81,089,156 Total debts 2022: € 81,089,156 ▲ 17% vs 2021 (€ 69,106,988) Unfavourable step	€ 88,775,885 Total debts 2023: € 88,775,885 ▲ 9% vs 2022 (€ 81,089,156) Unfavourable step	▲ 9%
Cash	€ 14,193,345 Cash 2021: € 14,193,345 First fiscal year in the series	€ 6,724,407 Cash 2022: € 6,724,407 ▼ 53% vs 2021 (€ 14,193,345) Unfavourable step	€ 3,288,967 Cash 2023: € 3,288,967 ▼ 51% vs 2022 (€ 6,724,407) Unfavourable step	▼ 51%
Land & buildings	€ 1,922,203 Land & buildings 2021: € 1,922,203 First fiscal year in the series	€ 3,898,425 Land & buildings 2022: € 3,898,425 ▲ 103% vs 2021 (€ 1,922,203) Unchanged	€ 5,235,526 Land & buildings 2023: € 5,235,526 ▲ 34% vs 2022 (€ 3,898,425) Unchanged	▲ 34%
Retained profit	€ 390,576 Retained profit 2021: € 390,576 First fiscal year in the series	€ 329,350 Retained profit 2022: € 329,350 ▼ 16% vs 2021 (€ 390,576) Unfavourable step	€ 27,567,210 Retained profit 2023: € 27,567,210 ▲ € 27.2 million vs 2022 (€ 329,350) Favourable step	▲ € 27.2 million
Bank debt	€ 59,561,916 Bank debt 2021: € 59,561,916 First fiscal year in the series	€ 74,980,165 Bank debt 2022: € 74,980,165 ▲ 26% vs 2021 (€ 59,561,916) Unfavourable step	€ 78,994,348 Bank debt 2023: € 78,994,348 ▲ 5% vs 2022 (€ 74,980,165) Unfavourable step	▲ 5%
Balance sheet total	€ 140,676,749 Balance sheet total 2021: € 140,676,749 First fiscal year in the series	€ 190,258,053 Balance sheet total 2022: € 190,258,053 ▲ 35% vs 2021 (€ 140,676,749) Unchanged	€ 231,616,732 Balance sheet total 2023: € 231,616,732 ▲ 22% vs 2022 (€ 190,258,053) Unchanged	▲ 22%
Employees (FTE)	62 Employees (FTE) 2021: 62 First fiscal year in the series	87.4 Employees (FTE) 2022: 87.4 ▲ 25.4 vs 2021 (62) Unchanged	83.6 Employees (FTE) 2023: 83.6 ▼ 3.8 vs 2022 (87.4) Unchanged	▼ 3.8

Key figures of UNIVERCELLS, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.

What happened to UNIVERCELLS?

What happened at UNIVERCELLS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

UNIVERCELLS is active according to the CBE. Legal situation: Opening faillissement.

2028 TIMOTHY E. MORRIS stepped down as director. NBB
2026 HUGUES BULTOT stepped down as director. NBB
2026 ANDRIN OSWALD stepped down as director. NBB
2026 CELINE VAESSEN stepped down as director. NBB
2026 JOSE ANTONIO CASTILLO stepped down as director. NBB
2026 PIERRE-ARMAND MORGON stepped down as director. NBB
2026 DOUGLAS NEUGOLD stepped down as director. NBB
2026 GLENN ROCKMAN stepped down as director. NBB

In short

From € 8.3 million loss in 2021 to € 20.4 million profit in 2023.

Best year ever: 2023, with € 20.4 million profit.

Pays suppliers within 58 days on average.

Original PDFs at the National Bank ↗

Management

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT 12.8%

CTJ CONSULTING

The stake of SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, CTJ CONSULTING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

UNIVERCELLS

QUANTOOM BIOSCIENCES 100%

RLM CONSULTING 100%

QUANTOOM FRANCE SARL 100%

UNIZIMA 100%

The shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (12.8%) and CTJ CONSULTING. It owns 100% of QUANTOOM BIOSCIENCES, 100% of RLM CONSULTING, 100% of QUANTOOM FRANCE SARL, 100% of UNIZIMA, 100% of EXOTHERA and 100% of QUANTOOM BIOSERVICES itself.

Directors

According to the 2023 annual accounts

HUGUES BULTOT

Managing director

Also active at: H ET B MANAGEMENT, EXOTHERA, UNIZIMA, Quantoom Biosciences, Quantoom Bioservices, RLM Consulting

since 2020 · until 2026

TIMOTHY E. MORRIS

Director

since 2022 · until 2028

ANDRIN OSWALD

Director

since 2020 · until 2026

CELINE VAESSEN

Director

since 2020 · until 2026

JOSE ANTONIO CASTILLO

Director

since 2020 · until 2026

PIERRE-ARMAND MORGON

Director

since 2020 · until 2026

DOUGLAS NEUGOLD

Chairman of the board

since 2020 · until 2026

GLENN ROCKMAN

Director

since 2020 · until 2026

Shareholders

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

12.8%

CTJ CONSULTING

Participations

QUANTOOM BIOSCIENCES

100%

RLM CONSULTING

100%

QUANTOOM FRANCE SARL

100%

UNIZIMA

100%

EXOTHERA

100%

QUANTOOM BIOSERVICES

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Zoning de Jumet,avenue Centrale 52

6040 Charleroi

2.216.424.957

Rue Auguste Piccard 48

6041 Charleroi

Active since 24 January 2013

2.239.899.254

Herrmann-Debrouxlaan 54

1160 Oudergem

Active since 31 January 2015

2.277.594.048

rue de la Maitrise 11

1400 Nivelles

Active since 27 June 2018

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

EXOTHERA same network

€ 10 million revenue · 2023

UNIZIMA same network

€ 1.8 million revenue · 2023

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0502.742.288
VAT number: BE 0502.742.288
Registered office: Zoning de Jumet,avenue Centrale 52, 6040 Charleroi
Names & denominations: UNIVERCELLS
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Opening faillissement
Start date: 24 January 2013
Peppol: Not registered
Activities · NACE: Vervaardiging van overige farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

UNIVERCELLS

Warning lights

Financials

What happened to UNIVERCELLS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions